GlassScriptPhysician profile
Luis Izquierdo
NPI 1780802447
$2,124.47
in general payments reported to CMS, 2019-2025
20 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $180 · 2021: $292 · 2022: $326 · 2023: $385 · 2024: $251 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $728 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $728.33 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $739.74 | 2019-2023 | Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $248.37 | 2019-2024 | Dupixent |
| Integra Lifesciences Corporation | $198.22 | 2024-2025 | Acclarent Aera, Inspira Air, Relieva Spinplus Nav |
| Genentech USA, INC. | $125.00 | 2019 | |
| Optinose US, INC. | $123.19 | 2019-2021 | |
| Carl Zeiss Meditec Cataract Technology INC. | $110.42 | 2024 | |
| Glaxosmithkline, LLC. | $107.10 | 2022-2025 | Nucala |
| Advanced Bionics, LLC | $104.80 | 2019-2020 | |
| Bard Access Systems, INC. | $94.02 | 2019 | |
| Stryker Corporation | $57.32 | 2019-2022 | |
| Depuy Synthes Sales INC. | $47.38 | 2022 | |
| Genzyme Corporation | $30.08 | 2021 | |
| Medtronic, INC. | $24.02 | 2022 | |
| Inspire Medical Systems, INC. | $21.39 | 2023 | Inspire |
| Hikma Pharmaceuticals USA | $19.53 | 2023 | Ryaltris |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $16.64 | 2024 | Immunocap |
| Kaleo, INC. | $16.28 | 2019 | |
| Alk-Abello, INC | $15.40 | 2019 | |
| Neurent Medical Limited | $14.33 | 2024 | Neuromark Device, Neuromark Radiofrequency Console |
| Arbor Pharmaceuticals, INC. | $11.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Izquierdo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.